Status:

COMPLETED

Hypotension Prediction Index Study (HPI Study)

Lead Sponsor:

Edwards Lifesciences

Conditions:

Hypotension

Eligibility:

All Genders

18+ years

Brief Summary

A prospective, single-arm, open-label, multicenter post-approval study to determine whether the use of the Acumen HPI Software to guide intraoperative hemodynamic management in non-cardiac surgery red...

Eligibility Criteria

Inclusion

  • Written informed consent;
  • Age ≥ 18 years;
  • ASA Physical Status 3 or 4;
  • Moderate- or high-risk non-cardiac surgery (for example, orthopedic, spine, urology, and general surgery);
  • Planned pressure monitoring with an arterial line;
  • General anesthesia;
  • Surgery duration expected to last ≥ 3 hours from induction;
  • Planned overnight hospitalization.

Exclusion

  • Participating in another (interventional) study;
  • Contraindication to the invasive blood pressure monitoring;
  • Patient who is confirmed to be pregnant and/or nursing mothers;
  • Emergency surgery;
  • Known clinically important intra-cardiac shunts;
  • Patient in whom an intraoperative MAP target will be \< 65 mmHg;
  • Known aortic stenosis with valve area ≤ 1.5 cm2;
  • Known moderate to severe aortic regurgitation;
  • Known moderate to severe mitral regurgitation;
  • Known moderate to severe mitral stenosis;
  • Patient or surgical procedure type known as an SVV limitation (5) (e.g. tidal volume \<8mL/kg of theoretical ideal weight, spontaneous ventilation, persistent cardiac arrhythmia, known atrial fibrillation, open chest surgery, Heart Rate/Respiratory Rate (HR/RR) ratio \<3.6);
  • Current persistent atrial fibrillation;
  • Known acute congestive heart failure;
  • Craniotomy;
  • Surgery duration expected to last \< 3 hours;
  • Burn surgeries;
  • Patients with an intra-aortic balloon pump (IABP) or ventricular assist device(s);
  • Patient transfer from ICU requiring multiple vasoactive agents and known diagnosis of ongoing active sepsis.

Key Trial Info

Start Date :

May 16 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 17 2020

Estimated Enrollment :

485 Patients enrolled

Trial Details

Trial ID

NCT03805217

Start Date

May 16 2019

End Date

March 17 2020

Last Update

October 18 2024

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Stanford Health Care

Stanford, California, United States, 94305

2

UCHealth University of Colorado Hospital

Aurora, Colorado, United States, 80045

3

Yale University

New Haven, Connecticut, United States, 06510

4

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114